Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)
China · Delayed Price · Currency is CNY 7.10
+0.16 (2.31%)
Aug 20, 2026, 3:04 PM CST
SHE:002550 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,468 | 1,571 | 1,526 | 1,814 | 2,304 | 1,875 |
Revenue Growth | -4.21% | 2.95% | -15.88% | -21.24% | 22.86% | 12.43% |
Gross Profit Gross Profit Growth | 824.53 | 905.92 | 829.94 | 768.81 | 884.31 | 829.44 |
Operating Income Operating Income Growth | 259.86 | 320.67 | 282.12 | 162.19 | 222.56 | 152.38 |
Net Income Net Income Growth | 293.57 | 398.8 | 356.03 | 181.86 | 323.41 | 181.08 |
Earnings Per Share EPS Growth | 0.23 | 0.32 | 0.28 | 0.14 | 0.25 | 0.15 |
EPS Growth | -30.91% | 14.29% | 100.00% | -44.00% | 66.67% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Biomedicine Biomedicine Growth | 1,319 | 1,532 | 1,522 | 1,807 | 2,298 | 1,873 |
Others Others Growth | 72.41 | 39.5 | 3.76 | 7.74 | 5.23 | 1.85 |
Total Total Growth | 1,468 | 1,571 | 1,526 | 1,814 | 2,304 | 1,875 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,227 | 1,161 | 906.67 | 713.16 | 476.73 | 686.03 |
Total Debt Total Debt Growth | 34.07 | 3.34 | 21.49 | 56.31 | 103.05 | 93.56 |
Net Cash (Debt) Net Cash Growth | 1,193 | 1,158 | 885.19 | 656.85 | 373.69 | 592.48 |
Net Cash Growth | 19.41% | 30.81% | 34.76% | 75.78% | -36.93% | -16.38% |
Net Cash Per Share Net Cash Per Share Growth | 0.95 | 0.93 | 0.70 | 0.51 | 0.29 | 0.49 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 393.81 | 361.36 | 514.71 | 533.33 | -71.47 | 103.56 |
Capital Expenditures CapEx Growth | -159.31 | -141.6 | -90.64 | -100.33 | -70.99 | -90.37 |
Free Cash Flow Free Cash Flow Growth | 234.51 | 219.76 | 424.07 | 433 | -142.46 | 13.19 |
Free Cash Flow Growth | -5.40% | -48.18% | -2.06% | - | - | -94.82% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 56.17% | 57.66% | 54.38% | 42.38% | 38.39% | 44.24% |
Operating Margin | 17.70% | 20.41% | 18.48% | 8.94% | 9.66% | 8.13% |
Pretax Margin | 22.10% | 28.65% | 25.94% | 11.22% | 15.64% | 11.17% |
Profit Margin | 20.00% | 25.38% | 23.33% | 10.02% | 14.04% | 9.66% |
FCF Margin | 15.98% | 13.99% | 27.79% | 23.87% | -6.18% | 0.70% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.150 | 0.150 | 0.120 | 0.120 | 0.120 | 0.120 |
Dividend Per Share Growth | 25.00% | 25.00% | 0% | 0% | 0% | 0% |
Dividend Yield | 2.06% | 1.96% | 2.02% | 2.17% | 2.08% | 2.76% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 30.24 | 24.63 | 21.76 | 41.38 | 24.77 | 34.14 |
Forward PE | - | 21.83 | 22.41 | 26.33 | 20.00 | 20.00 |
P/FCF Ratio | 37.84 | 44.70 | 18.27 | 17.38 | - | 468.80 |
PS Ratio | 6.05 | 6.25 | 5.08 | 4.15 | 3.48 | 3.30 |